Pharmacokinetics and biodistribution of a small radioiodine labeled nerve growth factor fragment

Annals of Nuclear Medicine

Volumn 20, Issue 8, 2006, Pages 535-540

  Jung, Kyung Ho ^a   Kim, Dong Hyun ^a   Paik, Jin Yung ^a   Ko, Bong Ho ^a   Bae, Jun Sang ^a   Choe, Yearn Seong ^a   Lee, Kyung Han ^a,b   Kim, Byung Tae ^a  

^a Sungkyunkwan University   (South Korea)

^b Samsung Medical Center   (South Korea)

Author keywords

Biodistribution; Nerve growth factor; Peptide; Pharmacokinetics; Radioiodine

Indexed keywords

BOLTON HUNTER REAGENT I 125; CYCLOPEPTIDE; NERVE GROWTH FACTOR; RADIOACTIVE IODINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CROSS LINKING; DOSE RESPONSE; DRUG CLEARANCE; DRUG DISTRIBUTION; LIVER; LUNG; MOUSE; NONHUMAN; PANCREAS; PRIORITY JOURNAL; RADIOIODINATION; SPLEEN;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IODINE RADIOISOTOPES; MICE; MICE, INBRED ICR; NERVE GROWTH FACTORS; NEURONS; PEPTIDES; PROTEIN BINDING; RECEPTOR, TRKA; RECEPTORS, NERVE GROWTH FACTOR; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 33751428733     PISSN: 09147187     EISSN: 09147187     Source Type: Journal    
DOI: 10.1007/BF03026817     Document Type: Article

References (23)

1. Pierchala BA, Ahrens RC, Paden AJ, Johnson EM Jr. Nerve growth factor promotes the survival of sympathetic neurons through the cooperative function of the protein kinase C and phosphatidylinositol 3-kinase pathways. J Biol Chem 2004; 279: 27986-27993.
2. Miao G, Mace J, Kirby M, et al. In vitro and in vivo improvement of islet survival following treatment with nerve growth factor. Transplantation 2006; 81: 519-524.
3. Rende M, Brizi E, Conner J, Treves S, Censier K, Provenzano C, et al. Nerve growth factor (NGF) influences differentiation and proliferation of myogenic cells in vitro via TrKA. Int J Dev Neurosci 2000; 18: 869-885.
4. Emanueli C, Salis MB, Pinna A, Graiani G, Manni L, Madeddu P. Nerve growth factor promotes angiogenesis and arteriogenesis in ischemic hindlimbs. Circulation 2002; 106: 2257-2262.
5. Bonini S, Rasi G, Bracci-Laudiero ML, Procoli A. Nerve growth factor: neurotrophin or cytokine? Int Arch Allergy Immunol 2003; 131: 80-84.
6. Apfel SC, Schwartz S, Adornato BT, et al. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator Group. JAMA 2000; 284: 2215-2221.
7. Apfel SC. Neurotrophic factors in the therapy of diabetic neuropathy. Am J Med 1999; 107: 34S-42S.
8. Pollack SJ, Harper SJ. Small molecule Trk receptor agonists and other neurotrophic factor mimetics. Curr Drug Targets CNS Neurol Disord 2002; 1: 59-80.
9. Nanduri J, Vroegop SM, Buxser SE, Neet KE. Immunological determinants of nerve growth factor involved in p140trk (Trk) receptor binding. J Neurosci Res 1994; 37: 433-444.
10. Kaplan DR, Hempstead BL, Martin-Zanca D, Chao MV, Parada LF. The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. Science 1991; 252: 554-558.
11. LeSauteur L, Wei L, Gibbs BF, Saragovi HU. Small peptide mimics of nerve growth factor bind TrkA receptors and affect biological responses. J Biol Chem 1995; 270: 6564-6569.
12. Maliartchouk S, Feng Y, Ivanisevic L, et al. A designed peptidomimetic agonistic ligand of TrkA nerve growth factor receptors. Mol Pharmacol 2000; 57: 385-391.
13. Debeir T, Saragovi HU, Cuello AC. A nerve growth factor mimetic TrkA antagonist causes withdrawal of cortical cholinergic boutons in the adult rat. Proc Natl Acad Sci USA 1999; 96: 4067-4072.
14. LeSauteur L, Cheung NK, Lisbona R, Saragovi HU. Small molecule nerve growth factor analogs image receptors in vivo. Nat Biotechnol 1996; 14: 1120-1122.
15. Pradier P, Jalenques I, Dalle M, Reuling R, Despres G, Romand R. Distribution and metabolism patterns of plasma 7S- and beta-NGF in the adult male rat. J Physiol Paris 1994; 88: 273-277.
16. Tria MA, Fusco M, Vantini G, Mariot R. Pharmacokinetics of nerve growth factor (NGF) following different routes of administration to adult rats. Exp Neurol 1994; 127: 178-183.
17. Nguyen CB, Harris L, Szonyi E, et al. Tissue Disposition and Pharmacokinetics of Recombinant human nerve growth factor after acute and chronic subcutaneous administration in monkeys. Drug Metabolism and Disposition 2000; 28: 598-607.
18. Schoenwald RD. Pharmacokinetics in drug discovery and development. Florida; CRC Press, 2002.
19. McMahon SB, Bennett DL, Priestley JV, Shelton DL. The biological effects of endogenous nerve growth factor on adult sensory neurons revealed by a trkA-IgG fusion molecule. Nat Med 1995; 1: 774-780.
20. Lomen-Hoerth C, Shooter EM. Widespread neurotrophin receptor expression in the immune system and other nonneuronal rat tissues. J Neurochem 1995; 64: 1780-1789.
21. Kanaka-Gantenbein C, Tazi A, Czernichow P, Scharfmann R. In vivo presence of the high affinity nerve growth factor receptor Trk-A in the rat pancreas: differential localization during pancreatic development. Endocrinology 1995; 136: 761-769.
22. Ricci A, Felici L, Mariotta S, et al. Neurotrophin and neurotrophin receptor protein expression in the human lung. Am J Respir Cell Mol Biol 2004; 30: 12-19.
23. Bailie MB, Roth RA, Contreras ML. Nerve growth factor binding sites on hepatic parenchymal cells. In Vitro Cell Dev Biol 1992; 28A: 621-624.